CARA logo

Carasent AB (publ) Stock Price

OM:CARA Community·SEK 1.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CARA Share Price Performance

SEK 26.80
0.75 (2.88%)
​
SEK 36.25
Fair Value
SEK 26.80
0.75 (2.88%)
26.1% undervalued intrinsic discount
SEK 36.25
Fair Value
Price SEK 26.80
AnalystConsensusTarget SEK 36.25
AnalystLowTarget SEK 34.00
AnalystHighTarget SEK 39.00

CARA Community Narratives

Fair Value
·
Fair Value SEK 36.25 26.1% undervalued intrinsic discount

Cloud EHR Adoption And New Modules Will Reshape This Nordic Health Software Provider

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Fair Value
·
Fair Value SEK 34 21.2% undervalued intrinsic discount

Cloud EHR Adoption And AI Tools Will Sustainably Shape Long-Term Earnings Trajectory

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Fair Value
·
Fair Value SEK 39 31.3% undervalued intrinsic discount

Cloud Healthcare Shift Will Drive Strong Market Share And Durable Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CARA logo
Carasent
26.1% undervalued intrinsic discount

Cloud EHR Adoption And New Modules Will Reshape This Nordic Health Software Provider

View narrative
Updated 10 Jul
Read Narrative
CARA logo
Carasent
21.2% undervalued intrinsic discount

Cloud EHR Adoption And AI Tools Will Sustainably Shape Long-Term Earnings Trajectory

View narrative
Updated 26 Jun
Read Narrative
CARA logo
Carasent
31.3% undervalued intrinsic discount

Cloud Healthcare Shift Will Drive Strong Market Share And Durable Earnings Power

View narrative
Published 6 Dec 2025
Read Narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CARA logo

CARA: Higher Revenue Assumptions And Bylaw Changes Will Support Upside

Fair Value: SEK 36.25 26.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CARA logo

CARA: Higher Growth Outlook And Governance Changes Will Support Upside

Fair Value: SEK 34 21.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CARA logo

Cloud Healthcare Shift Will Drive Strong Market Share And Durable Earnings Power

Fair Value: SEK 39 31.3% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
4 Rewards
View Full Analysis

Carasent AB (publ) Key Details

SEK 363.9m

Revenue

SEK 59.3m

Cost of Revenue

SEK 304.6m

Gross Profit

SEK 261.3m

Other Expenses

SEK 43.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 15, 2026
0.65
83.72%
11.91%
0%
View Full Analysis

About CARA

Founded
1997
Employees
236
CEO
Daniel Ohman
WebsiteView website
carasent.com

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.

Recent CARA News & Updates

Narrative Update • Jul 10

CARA: Higher Revenue Assumptions And Bylaw Changes Will Support Upside

Analysts have lifted their 12 month price target on Carasent to SEK36.25 from SEK32.09, citing updated assumptions for slightly higher revenue growth, a modestly lower discount rate, a small adjustment to profit margin expectations, and a higher future P/E multiple. What's in the News for Carasent Carasent held its Annual General Meeting on April 20, 2026, where shareholders approved amendments to the company’s articles of association.
Narrative Update • Jun 26

CARA: Higher Growth Outlook And Governance Changes Will Support Upside

Analysts have lifted their price target on Carasent to SEK34.00 from SEK25.27. This reflects updated assumptions that pair higher projected revenue growth with a lower profit margin and a much richer forward P/E multiple.

Recent updates

No updates

Carasent AB (publ) Competitors

GETI B logo

Getinge

Symbol: OM:GETI B
Market cap: SEK 64.3b
SECT B logo

Sectra

Symbol: OM:SECT B
Market cap: SEK 55.8b
MCOV B logo

Medicover

Symbol: OM:MCOV B
Market cap: SEK 39.1b
ASKER logo

Asker Healthcare Group

Symbol: OM:ASKER
Market cap: SEK 22.7b
View more competitors